Why cardiologists should be more interested in PAH
VBWG at ACC 2018 Prof. Gomberg-Maitland gives numerous reasons why cardiologist should be interested in PAH, including updated knowledge on genetics and pathophysiology and interestingly, novel targets for therapy and different therapy strategies.
Educational information
This 3-minute education provides a summary of just presented scientific data, recorded during the VBWG at ACC 2018. The objective is to provide a brief commentary and potential implications of these findings.
Faculty
Mardi Gomberg-Maitland is Professor of Internal Medicine at VCU School of Medicine and Director of the RV Failure, HFpEF, and Cardio-Oncology Programs, and CoDirector of the Pulmonary Vascular Disease Program at Inova Heart and VascularInstitute. She is an expert clinician and researcher in the field of pulmonary vascular disease with a focus on pulmonary arterial hypertension.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Online-CME
This is available as accredited online CME for members. Click the button below to enroll:
Enroll
Share this page with your colleagues and friends: